These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2475285

  • 21. Regulation of the C3 nephritic factor stabilized C3/C5 convertase of complement by purified human erythrocyte C3b receptor.
    Daha MR, Kok DJ, Van Es LA.
    Clin Exp Immunol; 1982 Oct; 50(1):209-14. PubMed ID: 6216999
    [Abstract] [Full Text] [Related]

  • 22. C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases.
    Zhao F, Afonso S, Lindner S, Hartmann A, Löschmann I, Nilsson B, Ekdahl KN, Weber LT, Habbig S, Schalk G, Kirschfink M, Zipfel PF, Skerka C.
    Front Immunol; 2019 Oct; 10():1030. PubMed ID: 31214159
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Mechanisms of action and clinical importance of C3-nephritic-factor (author's transl)].
    Lanzer G, Pogglitsch H, Tilz GP.
    Acta Med Austriaca; 1981 Oct; 8(1):7-13. PubMed ID: 6908995
    [Abstract] [Full Text] [Related]

  • 25. Loss of autoantibody activity by alteration in autoantigen.
    Spitzer RE, Stitzel AE.
    Clin Immunol Immunopathol; 1996 Aug; 80(2):211-3. PubMed ID: 8764567
    [Abstract] [Full Text] [Related]

  • 26. Different Aspects of Classical Pathway Overactivation in Patients With C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis.
    Michels MAHM, van de Kar NCAJ, van Kraaij SAW, Sarlea SA, Gracchi V, Engels FAPT, Dorresteijn EM, van der Deure J, Duineveld C, Wetzels JFM, van den Heuvel LPWJ, Volokhina EB.
    Front Immunol; 2021 Aug; 12():715704. PubMed ID: 34456924
    [Abstract] [Full Text] [Related]

  • 27. A C3 convertase assay for nephritic factor functional activity.
    Jelezarova E, Schlumberger M, Sadallah S, Späth PJ, Schifferli JA, Lutz HU.
    J Immunol Methods; 2001 May 01; 251(1-2):45-52. PubMed ID: 11292480
    [Abstract] [Full Text] [Related]

  • 28. A novel ELISA assay for the detection of C3 nephritic factor.
    Seino J, vd Wall Bake WL, van Es LA, Daha MR.
    J Immunol Methods; 1993 Feb 26; 159(1-2):221-7. PubMed ID: 8445254
    [Abstract] [Full Text] [Related]

  • 29. Composition of nephritic factor-generated glomerular deposits in membranoproliferative glomerulonephritis type 2.
    West CD, Witte DP, McAdams AJ.
    Am J Kidney Dis; 2001 Jun 26; 37(6):1120-30. PubMed ID: 11382679
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. C5 nephritic factors drive the biological phenotype of C3 glomerulopathies.
    Marinozzi MC, Chauvet S, Le Quintrec M, Mignotet M, Petitprez F, Legendre C, Cailliez M, Deschenes G, Fischbach M, Karras A, Nobili F, Pietrement C, Dragon-Durey MA, Fakhouri F, Roumenina LT, Fremeaux-Bacchi V.
    Kidney Int; 2017 Nov 26; 92(5):1232-1241. PubMed ID: 28712854
    [Abstract] [Full Text] [Related]

  • 32. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
    Watanabe S, Ohi H, Seki M, Fujita T, Hatano M.
    Nihon Jinzo Gakkai Shi; 1985 Oct 26; 27(10):1345-52. PubMed ID: 4094159
    [No Abstract] [Full Text] [Related]

  • 33. Autoantibody to complement neoantigens in membranoproliferative glomerulonephritis.
    Strife CF, Prada AL, Clardy CW, Jackson E, Forristal J.
    J Pediatr; 1990 May 26; 116(5):S98-102. PubMed ID: 2329415
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase.
    Jelezarova E, Lutz HU.
    Mol Immunol; 2005 Jul 26; 42(11):1393-403. PubMed ID: 15950735
    [Abstract] [Full Text] [Related]

  • 36. On the origin and control of C3NeF.
    Spitzer RE, Stitzel AE.
    In Vivo; 1988 Jul 26; 2(1):79-81. PubMed ID: 2979821
    [Abstract] [Full Text] [Related]

  • 37. Stabilization of homologous and heterologous cell-bound amplification convertases, C3bBb, by C3 nephritic factor.
    Daha MR, Van Es LA.
    Immunology; 1981 May 26; 43(1):33-8. PubMed ID: 6166544
    [Abstract] [Full Text] [Related]

  • 38. C3 nephritic factor can be associated with membranous glomerulonephritis.
    Niel O, Dallocchio A, Thouret MC, Guigonis V, Cassuto É, Frémeaux-Bacchi V, Bérard É.
    Pediatr Nephrol; 2015 Feb 26; 30(2):353-5. PubMed ID: 25395361
    [Abstract] [Full Text] [Related]

  • 39. Production of C3 nephritic factor by cultured lymphocytes derived from a patient with partial lipodystrophy.
    Yamada A, Ohi H, Okano K, Watanabe S, Seki M, Hatano M, Koitabashi Y.
    J Clin Lab Immunol; 1988 Sep 26; 27(1):35-7. PubMed ID: 3251045
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.